GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS Page 1

Glucotrack expands leadership team with clinical research expertise for continuous blood glucose monitoring for people with diabetes

Rutherford, NJ, Aug. 27, 2024 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development and commercialization of novel technologies for people with diabetes, today announced that Sandie Martha has joined the Company as Vice President of Clinical Operations.